Sunday, September 30, 2007 9:59:00 PM
They have a product that successfully went through Phase III, began making sales, and were hoping to partner it out and collect the royalty checks.
They announced a BP deal on Friday, the sp had been building from maybe 2.6 to 2.99 up to the announcement.
They get the announcement on Friday, and the share price falls 4%, still under 3 bucks. Granted, the exact numbers of Royalties were not announced in the press release, but THEY GOT THE DEAL, after months of speculation, and the sp went down.
I only point this out because it is not assured that Cortex "Soars" on a BP deal. We all hope so, be we have hoped for a lot in the past.
There are other competitors in the product in the IDIX field, as there are other AD/ADHD products in COR's field.
Many on this board were absolutely sure that Cor's share price would be right back to near 6 dollars, where it was before the clinical hold of CX717 and they bet hard earned money on that event. Once CX717 was released from the hold, as we all know, the share price only got appox half way back, and then only for a very short time frame.
Anyway, I was kind of stunned at that IDIX didn't take off through the roof and get a 20-30% pps pop, BUT IT WENT DOWN on partnering news..... One can argue the differences between IDIX and COR all day long, but there are some similarities, and to me, it certainly proves that even partnering is not a guaranteed slam dunk....
Bio's are in a really tough environment right now, and without some "sexy" or "hip" new slant on attacking a need, then the sales pitches are falling on deaf ears right now, imho....
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM